glp-1 information The revolution: What UAB researchers are discovering about how these drugs work Is GLP-1 Safe for Weight
Description
Lilly announces $3 billion expansion to injectable drug manufacturing facility for GLP-1 injectables
Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity
Promotes Regularity*
Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.
Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.
Xigduo XR package insert / prescribing information for healthcare professionals
